Fehlauer Fabian, Muench Martina, Rades Dirk, Stalpers Lukas J A, Leenstra Sieger, van der Valk Paul, Slotman Ben, Smid Ernst J, Sminia Peter
Department of Radiation Oncology, Universitätsklinikum Eppendorf, University of Hamburg, Martinistr. 52, 20254, Hamburg, Germany.
J Cancer Res Clin Oncol. 2005 Nov;131(11):723-32. doi: 10.1007/s00432-005-0014-3. Epub 2005 Nov 1.
Investigation of cell migration and proliferation of human glioma cell line spheroids (CLS) and evaluation of morphology, apoptosis, and immunohistochemical expression of MIB-1, p53, and p21 of organotypic muticellular spheroids (OMS) following cisplatin (CDDP) and irradiation (RT).
Spheroids of the GaMg glioma cell line and OMS prepared from biopsy tissue of six glioblastoma patients were used. Radiochemosensitvity (5 microg/ml CDDP followed by RT) was determined using migration and proliferation assays on CLS. In OMS, histology and immunohistochemical studies of MIB-1, p53, and p21 expression were examined 24 and 48 h following treatment.
Combination treatment led to a migration inhibition of 38% (CDDP 13%; RT 27%) and specific growth delay of 2.6 (CDDP 1.3; RT 2.1) in CLS. Cell cycle analysis after combination treatment showed an accumulation of cells in the G2/M phase. In OMS, apoptosis increased, cell proliferation decreased, and p53/p21 expression increased more pronounced following CDDP+RT. No morphological damage was observed.
CDDP can lead to enhancement of the RT effect in spheroids of both human glioma cell line spheroids and biopsy spheroids from glioblastoma specimens. The exerted effect is additive rather than synergistic.
研究顺铂(CDDP)和放疗(RT)后人类胶质瘤细胞系球体(CLS)的细胞迁移和增殖情况,并评估器官型多细胞球体(OMS)的形态、凋亡以及MIB-1、p53和p21的免疫组化表达。
使用GaMg胶质瘤细胞系球体以及由6例胶质母细胞瘤患者活检组织制备的OMS。通过对CLS进行迁移和增殖试验来测定放射化学敏感性(5μg/ml CDDP后接RT)。在OMS中,治疗后24小时和48小时检查MIB-1、p53和p21表达的组织学和免疫组化研究。
联合治疗导致CLS的迁移抑制率为38%(CDDP为13%;RT为27%),特异性生长延迟为2.6(CDDP为1.3;RT为2.1)。联合治疗后的细胞周期分析显示细胞在G2/M期积累。在OMS中,CDDP+RT后凋亡增加,细胞增殖减少,p53/p21表达增加更为明显。未观察到形态学损伤。
CDDP可增强人类胶质瘤细胞系球体和胶质母细胞瘤标本活检球体中RT的效果。所发挥的作用是相加的而非协同的。